Key result
A survey of 287 UK urologists revealed that 62% stop aspirin prior to transurethral prostatectomy, while 38% do not, demonstrating wide variation in peri-operative management.
Why the study?
What is the variation in peri-operative management of aspirin among UK urologists for patients undergoing transurethral prostatectomy?
Cross-Sectional (n=287)
What is the variation in peri-operative management of aspirin among UK urologists for patients undergoing transurethral prostatectomy?
Absolute Event Rate: 62% vs 38%
There is wide variation in the peri-operative management of aspirin for TURP among UK urologists, highlighting the need for multidisciplinary guidelines.
No takes yet. Share an insight, caveat, or question.
Practice variation in aspirin management for TURP warrants caution; leaves open optimal strategy pending prospective outcome data.
Enver et al. (2006) conducted a cross-sectional in Transurethral prostatectomy (TURP) in patients taking aspirin (n=287). Stopping aspirin prior to TURP vs. Not stopping aspirin was evaluated on Proportion of urologists who ask patients to stop aspirin prior to TURP. A survey of 287 UK urologists revealed that 62% stop aspirin prior to transurethral prostatectomy, while 38% do not, demonstrating wide variation in peri-operative management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: